Skip to main content
Back to European Investment Bank

European Investment Bank's Therapeutics Portfolio

Browse 9 Therapeutics companies funded by European Investment Bank. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
9
Total Funding in Therapeutics
$154.8M

Therapeutics Portfolio Companies (9)

Export
Therapeutics

Diadem is an innovative blood-based test exploiting a proprietary antibody targeting a specific conformation of p53 protein.

Brescia, Italy
September 2022
$2.5M
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.

Copenhagen, Denmark
September 2025
$6.6M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

ExeVir Bio is a Belgium-based company that develops single-domain antibody-based therapies that help patients ward off viral infections.

Zwijnaarde, Belgium
June 2023
$1.7M
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.

Amsterdam, The Netherlands
June 2026
$35.2M
Undisclosed

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)Medical DeviceNeuroscienceTherapeutics

INBRAIN Neuroelectronics is a BCI therapeutics company using graphene to build the least invasive and most intelligent neural platform

Barcelona, Spain
May 2025
$4.5M
Grant

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyTherapeutics

TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies.

Bordeaux, France
May 2025
$34.0M
Debt Financing

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareTherapeutics

Anocca is a clinical-stage biopharmaceutical company that develops T-cell receptors to treat infectious and autoimmune diseases.

Södertälje, Sweden
August 2025
$46.1M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

Health CareMedical DeviceTherapeutics

Xeltis is a clinical-stage medtech company with the world's most advanced polymer-based platform of restorative cardiovascular devices.

Eindhoven, The Netherlands
August 2023
$13.6M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up.

Lyon, France
November 2025
$10.6M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Explore European Investment Bank's Full Portfolio

View all companies funded by European Investment Bank across every industry and funding stage.

View Full European Investment Bank Portfolio